{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:40:26Z","timestamp":1733056826787,"version":"3.30.0"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3318,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1002\/hep.21273","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T18:47:45Z","timestamp":1153939665000},"page":"511","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Acute hepatitis C: Dosage and compliance"],"prefix":"10.1097","volume":"44","author":[{"given":"Francesco","family":"De Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cariti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-30-20241201","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha2b for acute hepatitis C infection: the HEPNET acuteHCVII study.","volume":"43","author":"Wiegand","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R2-30-20241201","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dki458","article-title":"Dosedependent and genotypeindependent sustained virological response of a 12 week pegylated interferon alpha2b treatment for acute hepatitis C.","volume":"57","author":"De Rosa","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R3-30-20241201","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":"Duration of peginterferon therapy in acute hepatitis C: a randomized trial.","volume":"43","author":"Kamal","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R4-30-20241201","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/135965350601100204","article-title":"The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferonalpha 2b.","volume":"11","author":"De Rosa","year":"2006","journal-title":"Antivir Ther"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21273","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200608000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:11:44Z","timestamp":1733055104000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200608000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21273","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}